Related Experiment Video
Updated: Aug 19, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Diagnosis and management of pertussis
Alberto E Tozzi1, Lucia Pastore Celentano, Marta Luisa Ciofi degli Atti
1Epidemiology Unit, Bambino Gesù Hospital, Rome, Italy. alberto.tozzi@opbg.net
Insights
Pertussis (whooping cough) is rising in all age groups due to waning immunity. Infants face the highest risk of severe pertussis illness, complications, and death.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Pertussis (whooping cough) incidence is increasing globally.
- Waning immunity in vaccinated individuals contributes to disease spread.
- Infants are most vulnerable to severe pertussis outcomes.
Purpose of the Study:
- To review the epidemiology and clinical presentation of pertussis.
- To discuss diagnostic challenges and limitations.
- To evaluate current therapeutic and prophylactic options.
Main Methods:
- Literature review of pertussis epidemiology, diagnosis, and treatment.
- Analysis of clinical presentations in different age groups.
- Evaluation of diagnostic test sensitivities and specificities.
Main Results:
- Increased pertussis frequency observed in unvaccinated children, adolescents, and adults.
- Atypical clinical presentations are common in vaccinated individuals.
- Diagnostic methods like culture and PCR have limited sensitivity, especially in later disease stages.
- Serologic tests lack standardization, limiting their clinical utility.
Conclusions:
- Pertussis resurgence necessitates improved vaccination strategies and public health awareness.
- Early diagnosis remains challenging due to atypical presentations and diagnostic test limitations.
- Macrolide antibiotics like azithromycin and clarithromycin offer effective treatment with fewer side effects than erythromycin.
Abstract:
Pertussis is increasing in frequency among children too young to be vaccinated and among adolescents and adults. This increase is due mainly to waning immunity among vaccinated individuals, who become susceptible during adolescence and adulthood and maintain the circulation of Bordetella pertussis. Infants are at highest risk of severe illness requiring hospital admission, complications and death. The clinical presentation in adolescents, adults and vaccinated individuals may be atypical, with paroxysmal cough of short duration or simply a persistent cough. Culture and polymerase chain reaction may be used to identify B. pertussis infection, but their sensitivity is high only in the early phase of the disease. Serologic tests are not standardized for the diagnosis of pertussis, and their clinical application is limited. Erythromycin is still considered in some countries to be the "gold standard" for therapy and prophylaxis; however, azithromycin and clarithromycin seem equally efficacious and are associated with fewer side effects.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pneumonia III: Complications and Assessment
